Rhode Island: Quest Resumes for AIDS Vaccine
October 21, 2005
Miriam Hospital in Providence, one of six centers chosen to test a new HIV vaccine, seeks 20 people ages 18-50 who can commit to coming to the hospital about once a month for a year to test a new HIV vaccine. The National Institutes of Health-funded study involves a vaccine composed of fragments of HIV virus that are attached to a deactivated adenovirus. It is hoped that if the inoculated person is later exposed to HIV, the T-cells should be primed to fight it off. The vaccine has been shown to be safe in Phase I trials. Phase II trials will assess its ability to provoke an immune response. If so, Phase III will determine whether it prevents HIV.
10.13.2005; Felice J. Freyer
Pacific Islands Face "Urgent Challenge" to Address HIV/AIDS, UNAIDS Official Says Ahead of Conference
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.